P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies

Zhong Gao Xu, Dong Ryeol Ryu, TaeHyun Yoo, Dong Sub Jung, Jin Ju Kim, Hyung Jong Kim, Hoon Young Choi, Joo Seong Kim, Sharon G. Adler, Rama Natarajan, Dae Suk Han, Shin-Wook Kang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.

Original languageEnglish
Pages (from-to)524-531
Number of pages8
JournalNephrology Dialysis Transplantation
Volume20
Issue number3
DOIs
Publication statusPublished - 2005 Mar 1

Fingerprint

Podocytes
Cadherins
Glucose
Protein Kinase C
Messenger RNA
Protein C Inhibitor
Diabetic Nephropathies
Protein Kinase Inhibitors
Proteins
Proteinuria
Fluorescent Antibody Technique
Glomerular Filtration Barrier
Western Blotting
RNA
Staining and Labeling
In Vitro Techniques
Mannitol
Streptozocin
Diaphragm
Reverse Transcription

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Transplantation

Cite this

Xu, Zhong Gao ; Ryu, Dong Ryeol ; Yoo, TaeHyun ; Jung, Dong Sub ; Kim, Jin Ju ; Kim, Hyung Jong ; Choi, Hoon Young ; Kim, Joo Seong ; Adler, Sharon G. ; Natarajan, Rama ; Han, Dae Suk ; Kang, Shin-Wook. / P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. In: Nephrology Dialysis Transplantation. 2005 ; Vol. 20, No. 3. pp. 524-531.
@article{3c2514e0940745d38ca8acb8329823d7,
title = "P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies",
abstract = "Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42{\%} and 62{\%}, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.",
author = "Xu, {Zhong Gao} and Ryu, {Dong Ryeol} and TaeHyun Yoo and Jung, {Dong Sub} and Kim, {Jin Ju} and Kim, {Hyung Jong} and Choi, {Hoon Young} and Kim, {Joo Seong} and Adler, {Sharon G.} and Rama Natarajan and Han, {Dae Suk} and Shin-Wook Kang",
year = "2005",
month = "3",
day = "1",
doi = "10.1093/ndt/gfh642",
language = "English",
volume = "20",
pages = "524--531",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

Xu, ZG, Ryu, DR, Yoo, T, Jung, DS, Kim, JJ, Kim, HJ, Choi, HY, Kim, JS, Adler, SG, Natarajan, R, Han, DS & Kang, S-W 2005, 'P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies', Nephrology Dialysis Transplantation, vol. 20, no. 3, pp. 524-531. https://doi.org/10.1093/ndt/gfh642

P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. / Xu, Zhong Gao; Ryu, Dong Ryeol; Yoo, TaeHyun; Jung, Dong Sub; Kim, Jin Ju; Kim, Hyung Jong; Choi, Hoon Young; Kim, Joo Seong; Adler, Sharon G.; Natarajan, Rama; Han, Dae Suk; Kang, Shin-Wook.

In: Nephrology Dialysis Transplantation, Vol. 20, No. 3, 01.03.2005, p. 524-531.

Research output: Contribution to journalArticle

TY - JOUR

T1 - P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies

AU - Xu, Zhong Gao

AU - Ryu, Dong Ryeol

AU - Yoo, TaeHyun

AU - Jung, Dong Sub

AU - Kim, Jin Ju

AU - Kim, Hyung Jong

AU - Choi, Hoon Young

AU - Kim, Joo Seong

AU - Adler, Sharon G.

AU - Natarajan, Rama

AU - Han, Dae Suk

AU - Kang, Shin-Wook

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.

AB - Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.

UR - http://www.scopus.com/inward/record.url?scp=20144381750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144381750&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfh642

DO - 10.1093/ndt/gfh642

M3 - Article

VL - 20

SP - 524

EP - 531

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 3

ER -